Yu Xu

3PUBLICATIONS
2CO-AUTHORS
Molecular targetsBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 23, 2026
Discovery of LB10, a Potent and Orally Bioavailable Inhibitor of Ecto-5'-Nucleotidase as a Single Agent or in Combination for the Treatment of Lung Cancer.

|May 26, 2026
Discovery of Pyrrolo[1',2':1,6]pyrimido[5,4-c]pyridazin-6(5H)-one Derivatives as Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 Inhibitors.

|Oct 10, 2024
Discovery of Novel 5-(Pyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione Derivatives as Potent and Orally Bioavailable Inhibitors Targeting Ecto-5'-nucleotidase.

Yu Xu, Dan Liu, Wenzhuang Zhang

Pageof 1

Frequent Collaborators

3 joint publications

Yisheng Lai

1 joint publications

Cuijie Nong